Product Information
CLINDAMYCIN PH 1% GEL is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.1424 per GM under NDC 00168020230. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 28, 2000. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
NDC
00168020230
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA064160FDA Approved
1/28/2000
TE Code
AB1
On Market Since
1/28/2000
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PH 1% GEL has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 91.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1424 per GM |
|---|---|
| All-time high | $2.0045 (Dec 14, 2016) |
| All-time low | $0.1372 (Jul 22, 2026) |
| 52-week high | $0.1599 |
| 52-week low | $0.1372 |
| Median price | $1.1592 |
| Average price | $1.0662 |
| Largest weekly change | -40.7% (Oct 23, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PH 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PH 1% GEL, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.1424 per GM (NDC 00168020230), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PH 1% GEL changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PH 1% GEL has declined 91.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PH 1% GEL?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN PH 1% GEL has ranged from a low of $0.1372 (Jul 22, 2026) to a high of $2.0045 (Dec 14, 2016), with a median of $1.1592 per GM.
Are there cheaper alternatives to CLINDAMYCIN PH 1% GEL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN PH 1% GEL, is $0.1307 per GM — about 8% below CLINDAMYCIN PH 1% GEL.
Who manufactures CLINDAMYCIN PH 1% GEL?
CLINDAMYCIN PH 1% GEL (NDC 00168020230) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.